As of July, 26 major companies and nine of the top 10 global drugmakers were under corporate integrity agreements, Boston University law professor Kevin Outterson wrote in an NEJM op-ed, noting that rather than piecemeal measures, legislators should consider tougher laws to deter corporate misbehavior.

The MedBiquitous standards consortium is supporting FDA’s REMS initiative for ER/LA opioids by enabling data about compliant CE programs from across the health professions to be aggregated.

Physicians’ Education Resource (PER), an accredited CME provider, named Harold Magazine, PhD, as president. PER also named Alexis A.M. Mascitti, MD, as the company’s VP of scientific affairs.

CECity said it launched a cloud-based “learning health system” platform to Blue Cross Blue Shield executives from across the country at their 2012 Blue National Summit.

CBI’s 14th Annual Forum on Off-Label Guidelines is set for October 11–12 at the Doubletree Hotel Center City in Philadelphia. It’s intended to help companies ensure their medical and promotional information complies with off-label regulations.